Benfu He
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Protease and Inhibitor Mechanisms
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- PI3K/AKT/mTOR signaling in cancer
Papers in
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
-
- Circular RNAs in diseases 3
- RNA modifications and cancer 1
- Kruppel-like factors research 1
- Co-authors
- Jincan He (1 shared paper)Xiangming Mao (1 shared paper)Ziqing Wu (1 shared paper)Rongcheng Luo (5 shared papers)Ruxiang Xu (1 shared paper)Li Tan (1 shared paper)Dayong Zheng (2 shared papers)Na Huang (1 shared paper)
In The Last Decade
Benfu He
18 papers receiving 419 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 257
- Molecular Biology 267
- Oncology 46
- Hepatology 10
- Genetics 36
Countries citing papers authored by Benfu He
This map shows the geographic impact of Benfu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benfu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benfu He more than expected).
Fields of papers citing papers by Benfu He
This network shows the impact of papers produced by Benfu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benfu He. The network helps show where Benfu He may publish in the future.
Co-authors
The 25 scholars most cited alongside Benfu He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 103 | |
| 2 | 2012 | 90 | |
| 3 | 2013 | 62 | |
| 4 | 2014 | 38 | |
| 5 | 2014 | 29 | |
| 6 | 2012 | 24 | |
| 7 | 2020 | 17 | |
| 8 | 2009 | 14 | |
| 9 | 2011 | 12 | |
| 10 | 2016 | 9 | |
| 11 | 2013 | 9 | |
| 12 | [MiR-143 inhibits migration of human nasopharyngeal carcinoma cells by negatively regulating GLI3 gene]. | 2013 | 5 |
| 13 | 2016 | 4 | |
| 14 | [Expression of miR-143 in nasopharyngeal carcinoma cell lines and its effect on cell adhesion ability]. | 2013 | 2 |
| 15 | 2016 | 2 | |
| 16 | [Gefitinib enhances the radiosensitivity of nasopharyngeal carcinoma cell line CNE2 in vitro]. | 2011 | 2 |
| 17 | [Preliminary study of XELOX regimen as the first-line chemotherapy in advanced or recurrent gastric cancer]. | 2010 | 1 |
| 18 | 2024 | 1 | |
| 19 | 2025 | 0 |
About Benfu He
Benfu He is a scholar working on Cancer Research, Molecular Biology, Genetics, Hepatology and Safety Research, having authored 19 papers that have together received 424 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (3 papers), Cancer-related molecular mechanisms research (3 papers), BRCA gene mutations in cancer (2 papers), RNA modifications and cancer (1 paper), Ethics and Social Impacts of AI (1 paper), Kruppel-like factors research (1 paper) and Salivary Gland Tumors Diagnosis and Treatment (1 paper). The work is most often cited by research in Cancer Research (257 citations), Molecular Biology (267 citations), Oncology (46 citations), Hepatology (10 citations) and Genetics (36 citations). Benfu He has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Jincan He, Xiangming Mao, Ziqing Wu, Rongcheng Luo, Ruxiang Xu, Li Tan, Dayong Zheng, Na Huang, Feiye Liu and Jing Lin. Their work appears in journals such as OncoTargets and Therapy, Breast Cancer Research and Treatment, The Prostate, World Journal of Gastroenterology and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.